Follow last change Sep 2020 re-read 3 minutes ago

cLSC

Developed for: limbal stem cell deficiency
Investigated by: California Institute for Regenerative Medicine (CIRM) · National Eye Institute (NEI) · University of California, Los Angeles

today NCT03957954 · Ph 1

2021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03957954	Sep 2020 → Feb 2027 expected	limbal stem cell deficiency	University of California, Los Angeles	Active not recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	cLSC	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03957954 ↗
Modality	Cell therapy	“cultivated autologous limbal stem cells (cLSC)” NCT03957954 ↗